1. Home
  2. GNFT vs PINE Comparison

GNFT vs PINE Comparison

Compare GNFT & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • PINE
  • Stock Information
  • Founded
  • GNFT 1999
  • PINE 2019
  • Country
  • GNFT France
  • PINE United States
  • Employees
  • GNFT N/A
  • PINE N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • PINE Real Estate Investment Trusts
  • Sector
  • GNFT Health Care
  • PINE Real Estate
  • Exchange
  • GNFT Nasdaq
  • PINE Nasdaq
  • Market Cap
  • GNFT 202.6M
  • PINE 245.5M
  • IPO Year
  • GNFT 2019
  • PINE 2019
  • Fundamental
  • Price
  • GNFT $3.63
  • PINE $16.36
  • Analyst Decision
  • GNFT Strong Buy
  • PINE Strong Buy
  • Analyst Count
  • GNFT 1
  • PINE 9
  • Target Price
  • GNFT $13.00
  • PINE $19.72
  • AVG Volume (30 Days)
  • GNFT 9.4K
  • PINE 84.9K
  • Earning Date
  • GNFT 04-03-2025
  • PINE 04-17-2025
  • Dividend Yield
  • GNFT N/A
  • PINE 6.83%
  • EPS Growth
  • GNFT N/A
  • PINE N/A
  • EPS
  • GNFT 0.47
  • PINE 0.14
  • Revenue
  • GNFT $86,225,222.00
  • PINE $52,227,000.00
  • Revenue This Year
  • GNFT $145.20
  • PINE N/A
  • Revenue Next Year
  • GNFT N/A
  • PINE $4.37
  • P/E Ratio
  • GNFT $7.81
  • PINE $117.61
  • Revenue Growth
  • GNFT 175.45
  • PINE 14.42
  • 52 Week Low
  • GNFT $3.11
  • PINE $14.33
  • 52 Week High
  • GNFT $6.42
  • PINE $19.42
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 47.85
  • PINE 43.84
  • Support Level
  • GNFT $3.11
  • PINE $16.23
  • Resistance Level
  • GNFT $3.72
  • PINE $16.72
  • Average True Range (ATR)
  • GNFT 0.23
  • PINE 0.22
  • MACD
  • GNFT -0.02
  • PINE 0.01
  • Stochastic Oscillator
  • GNFT 56.85
  • PINE 25.00

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About PINE Alpine Income Property Trust Inc.

Alpine Income Property Trust Inc is a real estate company. It owns and operates a portfolio of single-tenant commercial properties. The company's portfolio is comprised of single-tenant retail and office properties located in or in close proximity to MSAs, growth markets and other markets in the United States. Their portfolio consists of One thirty eight net leased properties located in Hundred and four markets in thirty five states. The majority of the firm's revenue includes rental revenue derived from the ownership and leasing of property.

Share on Social Networks: